- Exchange: Tel Aviv
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Clal Biotechnology Industries Ltd
+ Add to WatchlistCBI:IT
736.30 ILs 25.20 3.31%As of 09:24:40 ET on 05/23/2013.
Snapshot for Clal Biotechnology Industries Ltd (CBI)
| Open: | 744.00 | Day's Range: | 730.00 - 748.80 | Volume: | 313,760 |
|---|---|---|---|---|---|
| Previous Close: | 736.30 | 52wk Range: | 701.00 - 1,411.87 | 1-Yr Rtn: | -40.62% |
Key Statistics for CBI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. TA-100 | - |
| Earnings Per Share (ttm) | -0.7105 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M ILS) | 891.18 |
| Shares Outstanding (M) | 121.03 |
| 30 Day Average Volume | 424,314 |
| Price/Book (mrq) | 0.8098 |
| Price/Sale (ttm) | 109.0462 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CBI
Company Profile & Key Executives for CBI
Clal Biotechnology Industries Ltd., invests in companies within the biological sector.
| Avraham Matityahu Fischer "Avi"Chairman | Ruben KrupikChief Executive Officer |
| Gil MilnerCFO/Controller | Amos BankirerVP:Strategy & Business Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CBI News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page